Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc. (CYCC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CYCC · as of Jun 9, 2026
Key Statistics
Explore Cyclacel Pharmaceuticals, Inc. Data
cycc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 71.4%
The CYCC analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $1.00, representing -84.29% downside from the current price of $6.37.
Competitors & Peers
cycc competitorsCYCC
AMTI
APGN
EPIX
GLS
IMVIFStock Performance
Full HistoryAbout Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development stage, focused on discovering and advancing treatments for various cancers and other diseases involving…
what is cyclacel pharmaceuticals, inc. · cycc stock overview · cyclacel pharmaceuticals, inc. company profile · who is cyclacel pharmaceuticals, inc. ceo · cycc NASDAQ · cyclacel pharmaceuticals, inc. headquarters · cyclacel pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Cyclacel Pharmaceuticals, Inc. (CYCC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 16, 2004. As of the latest trading session, CYCC stock price is $6.37, with a market capitalization of $10.6M. The stock has returned -96.68% over the past 12 months and -92.85% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Cyclacel Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $1.00. In fiscal year 2025, Cyclacel Pharmaceuticals, Inc. reported revenue of $747000.00 and net income of -$3.0M. For detailed data — including Cyclacel Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cyclacel Pharmaceuticals, Inc. (CYCC) stock price is $6.37. The stock is traded on NASDAQ under the ticker symbol CYCC. The 52-week range is $3.08 – $597.60.